As of 2025-07-11, the Relative Valuation of Novacyt SA (ALNOV.PA) is (17.91) EUR. This relative valuation is based on P/E multiples. With the latest stock price at 0.48 EUR, the upside of Novacyt SA based on Relative Valuation is -3871.4%.
The range of the Relative Valuation is (17.03) - (19.00) EUR.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 28.8x - 39.4x | 33.8x |
| Forward P/E multiples | 23.3x - 32.1x | 26.8x |
| Fair Price | (17.03) - (19.00) | (17.91) |
| Upside | -3684.7% - -4100.4% | -3871.4% |
| Date | P/E |
| 2025-07-10 | -0.80 |
| 2025-07-09 | -0.80 |
| 2025-07-08 | -0.79 |
| 2025-07-07 | -0.81 |
| 2025-07-04 | -0.81 |
| 2025-07-03 | -0.83 |
| 2025-07-02 | -0.83 |
| 2025-07-01 | -0.84 |
| 2025-06-30 | -0.83 |
| 2025-06-27 | -0.83 |
| 2025-06-26 | -0.81 |
| 2025-06-25 | -0.80 |
| 2025-06-24 | -0.83 |
| 2025-06-23 | -0.83 |
| 2025-06-20 | -0.85 |
| 2025-06-19 | -0.85 |
| 2025-06-18 | -0.85 |
| 2025-06-17 | -0.85 |
| 2025-06-16 | -0.85 |
| 2025-06-13 | -0.90 |
| 2025-06-12 | -0.98 |
| 2025-06-11 | -0.95 |
| 2025-06-10 | -0.96 |
| 2025-06-09 | -0.94 |
| 2025-06-06 | -0.93 |
| 2025-06-05 | -0.92 |
| 2025-06-04 | -0.95 |
| 2025-06-03 | -0.92 |
| 2025-06-02 | -0.96 |
| 2025-05-30 | -0.97 |
| 2025-05-29 | -0.98 |
| 2025-05-28 | -0.92 |
| 2025-05-27 | -0.98 |
| 2025-05-26 | -1.22 |
| 2025-05-23 | -0.90 |
| 2025-05-22 | -0.77 |
| 2025-05-21 | -0.80 |
| 2025-05-20 | -0.78 |
| 2025-05-19 | -0.79 |
| 2025-05-16 | -0.76 |
| 2025-05-15 | -0.78 |
| 2025-05-14 | -0.79 |
| 2025-05-13 | -0.80 |
| 2025-05-12 | -0.79 |
| 2025-05-09 | -0.77 |
| 2025-05-08 | -0.77 |
| 2025-05-07 | -0.76 |
| 2025-05-06 | -0.75 |
| 2025-05-05 | -0.75 |
| 2025-05-02 | -0.76 |